NCT07262970 2025-12-04Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorRezoluteAvailable
NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT02955446 2019-02-01Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor MalignanciesUniversity of Colorado, DenverNo longer available
NCT00481559 2014-01-17Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate ToxicityBTG International Inc.Approved for marketing